Literature DB >> 1979431

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

F Javoy-Agid1, E C Hirsch, S Dumas, C Duyckaerts, J Mallet, Y Agid.   

Abstract

Parkinson's disease is associated with a massive loss in melanized dopaminergic neurons in the substantia nigra resulting in a severe striatal dopaminergic denervation. The hyperactivity which develops in the remaining striatal dopaminergic terminals may be related to an increased rate of tyrosine hydroxylation. This could be related to changes in the level of expression of the gene coding for tyrosine hydroxylase. Thus, the detection of tyrosine hydroxylase messenger RNA was looked for at cellular levels by in situ hybridization histochemistry. Image analysis shows that the hybridization signal was significantly reduced in the surviving neurons when compared to control. The subnormal tyrosine hydroxylase messenger RNA content may express a change in level of tyrosine hydroxylase gene transcription, possibly in relation to sustained suffering of the neurons still present at late stages of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979431     DOI: 10.1016/0306-4522(90)90389-l

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Altered neurofilament expression does not contribute to Lewy body formation.

Authors:  C Bergeron; C Petrunka; L Weyer; M S Pollanen
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

2.  Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease.

Authors:  W P Gai; J C Vickers; P C Blumbergs; W W Blessing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

3.  Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.

Authors:  M Gomez-Gallego; E Fernandez-Villalba; A Fernandez-Barreiro; M T Herrero
Journal:  J Neural Transm (Vienna)       Date:  2006-09-21       Impact factor: 3.575

4.  Activation of tyrosine hydroxylase mRNA translation by cAMP in midbrain dopaminergic neurons.

Authors:  Xiqun Chen; Lu Xu; Pheona Radcliffe; Baoyong Sun; A William Tank
Journal:  Mol Pharmacol       Date:  2008-03-18       Impact factor: 4.436

5.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.

Authors:  M J Bannon; M S Poosch; Y Xia; D J Goebel; B Cassin; G Kapatos
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 6.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

7.  Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.

Authors:  O Strada; S Vyas; E C Hirsch; M Ruberg; A Brice; Y Agid; F Javoy-Agid
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 8.  Dopamine and aging: intersecting facets.

Authors:  C David Rollo
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

9.  Induction of tyrosine hydroxylase mRNA by nicotine in rat midbrain is inhibited by mifepristone.

Authors:  Pheona M Radcliffe; Carol R Sterling; A William Tank
Journal:  J Neurochem       Date:  2009-03-23       Impact factor: 5.372

10.  A micro-silicon chip for in vivo cerebral imprint in monkey.

Authors:  Affif Zaccaria; Ali Bouamrani; Laurent Selek; Michelle El Atifi; Anne Marie Hesse; Aurélie Juhem; David Ratel; Herve Mathieu; Yohann Coute; Christophe Bruley; Jerome Garin; Alim L Benabid; Stephan Chabardes; Brigitte Piallat; François Berger
Journal:  ACS Chem Neurosci       Date:  2013-01-15       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.